---
title: "Series B | Altss Taxonomy"
description: "Series B investing targets companies scaling distribution and operations, where execution risk shifts to growth efficiency, org build, and competitive…"
canonical: "https://altss.com/taxonomy/series-b"
---

Asset Class

# Series B

Publisher: Altss LLCPublished 2026-01-08Content modified 2026-01-08

Series B investing targets companies scaling distribution and operations, where execution risk shifts to growth efficiency, org build, and competitive dynamics. Allocators evaluate Series B through durability of retention, margin expansion potential, governance, and realistic liquidity pathways.

At Series B, companies typically have product-market fit and are scaling GTM. Risk concentrates in **growth efficiency**, **competition**, and **organizational execution**, while pricing becomes more sensitive to market cycles.

### How allocators define Series B exposure

Segmentation includes:

- **Growth quality:** retention and expansion vs acquisition-driven growth

- **Efficiency:** CAC payback, margin trajectory, operating leverage

- **Competitive moat:** switching costs, distribution advantage, platform depth

- **Governance and hiring:** ability to scale leadership and processes

- **Liquidity path:** strategic buyer universe or IPO feasibility

- **Valuation sensitivity:** impact of public comps and rate regime

Allocator framing:
**“Is this scalable durable growth—or fragile growth that breaks in a tighter market?”**

### Core strategies

- **Lead B:** governance and scaling expertise matters

- **Growth-sleeve B:** crossover-like behavior; must manage liquidity cycles

- **Sector-specific B:** underwriting deep category dynamics

### Evaluation

Conviction increases when managers show:

- repeatable ability to underwrite and scale GTM

- disciplined entry pricing relative to exit scenarios

- governance track record through hiring and scaling crises

- transparent reserves and pro-rata strategy

- evidence from downturn vintages

### What slows decisions

- dependence on “growth at all costs” era playbooks

- unclear path to profitability or durable unit economics

- high multiple exposure without downside protection

- crowded sectors with weak differentiation

### Misconceptions

- “Later stage means lower risk” → multiple compression and liquidity risk can dominate.

- “Revenue equals safety” → revenue quality and retention matter.

### Key allocator questions

- What breaks first if growth slows—retention, pricing, or CAC?

- What is the base-case liquidity path and timeline?

- How does valuation look under conservative exit multiples?

- What is the manager’s plan in a down-round environment?

- How does the manager support operational scaling?

## Key Takeaways

- Series B is execution underwriting with strong valuation sensitivity

- Durable retention and efficiency determine survivability

- Realistic liquidity pathways are required for institutional conviction

## Related terms

[Venture Capital (VC)](https://altss.com/taxonomy/venture-capital)[Operating Partner](https://altss.com/glossary/operating-partner)[Exit Strategy](https://altss.com/glossary/exit-strategy)

[Previous article

SeedingAsset Class](https://altss.com/taxonomy/seeding)[Next article

Series C+ / Late StageAsset Class](https://altss.com/taxonomy/series-c-late-stage)

## Canonical URL

https://altss.com/taxonomy/series-b